- A cluster of impairment that define why activity limitations and participation restrictions exist
2
New cards
- OR medical diagnosis
3
New cards
What questions should you ask yourself when it comes to evidence?
- Does the study provide information that is potentially relevant to my patient
4
New cards
- Is the information reasonably applicable to me
5
New cards
- Will the information affect my clinical decision
6
New cards
Diagnostic tests in PT are designed for
-assist in identifying key impairments
7
New cards
-define pathology (diagnostic label)
8
New cards
-indicate when to refer to MD
9
New cards
-can include "special tests"
10
New cards
Strategies for Clinical Diagnosis
-pattern recognition model
11
New cards
-multiple branching method
12
New cards
-exhaustion method
13
New cards
-hypothetico-deductive method
14
New cards
What clinical diagnosis strategy is most prone to error
pattern recognition model
15
New cards
Strategy for Clinical Diagnosis - Pattern Recognition Method
- The instantaneous realization that the patient's presentation conforms to a previously learned picture or pattern
16
New cards
- pathogenetic: characteristics/indicative of particular disease or condition
17
New cards
Strategy for Clinical Diagnosis - Multiple Branching Method
- The progression of the diagnostic process down but one of a large number of potential, preset paths by a method in which the response to each diagnostic inquiry automatically determines the next inquiry to be carried out
18
New cards
- follow yes/no algorithm
19
New cards
Strategy for Clinical Diagnosis - Exhaustion Method
- The painstaking, invariant search for (but paying no immediate attention to) all medical facts about the patient, followed by sifting through the data for the diagnosis
20
New cards
- of all possible options, only thing that's left
21
New cards
-typical medical model approach, time consuming, can lead to false positives
22
New cards
Strategy for Clinical Diagnosis - Hypothetico-deductive Method
- Formulation, from the earliest clues about the patient, of a 'short list' of potential diagnoses or actions, followed by the performance of those clinical (history and physical) maneuvers that will best reduce the length of the list
23
New cards
-efficient, minimize risk of false positivies
24
New cards
Most preferred and defensible Strategy for Clinical Diagnosis
hypothetico-deductive method
25
New cards
Diagnostic Evidence
- Usually in the form of a single study designed to determine the diagnostic utility of a procedure of set of procedures
26
New cards
The STARD statement
STAndard for the Reporting of Diagnostic accuracy studied consisting of 25 points
27
New cards
4 Key Points of STARD Statement
1. Independent, blind comparison with a reference standard
28
New cards
2. What the diagnostic test evaluated in an appropriate spectrum of patients?
29
New cards
3. Reference standard applied regardless of the diagnostic test results
30
New cards
4. Was the diagnostic test validated in a second, independent group of patients?
31
New cards
STARD (independent, blind comparison with a reference (gold) standard)
- Patients in the study have both tests performed (diagnostic and reference standard)
32
New cards
- Clinical performing tests have no knowledge of gold standard results (masked or blinded)
33
New cards
- Similar to concurrent validity - disease is right now, not later
34
New cards
STARD (What the diagnostic test evaluated in an appropriate spectrum of patients?)
- All could feasibly have the target disorder
35
New cards
- Complete range of severity of target disorder
36
New cards
- Disorders that could be confused with target disorder
37
New cards
- Can cause bias for examiner, need appropriate sample portion
38
New cards
STARD (Reference standard applied regardless of the diagnostic test results)
- May be tempting to forgo reference standard when negative diagnostic test results
39
New cards
- But tells only part of the story (eliminates critical information)
40
New cards
STARD (Was the diagnostic test validated in a second, independent group of patients?)
- Tells us about the 'stability' of the diagnostic test
41
New cards
- Least important
42
New cards
True Positive
- Subjects with disease and who test positive
43
New cards
False Positive
- Subjects without disease and who test positive
44
New cards
False Negative
- Subjects with disease who test negative
45
New cards
True Negative
- Subjects without disease who test negative
46
New cards
Formula for sensitivity
= (Patients with the condition who test positive)/(all patients with the condition)
*Proportion of patients with negative test who do not have the condition
58
New cards
Two problems associated with the use of predictive values
1. They are prevalence dependent - as prevalence falls, the positive predictive value falls and the negative predictive value increases
59
New cards
2. They can only be calculated for two levels of the test result (+ or -)
60
New cards
Effect of prevalence on predictive value
- do not do tests on patients with very low probability of having a positive test
61
New cards
- as pre-test probability falls then positive predictive value falls, negative predictive value increases
62
New cards
What is often a better alternative to predictive values when you have a low pre-test pobablility
likelihood ration
63
New cards
To increase prevalence
increase PPV
64
New cards
decrease NPV
65
New cards
SpPin
- When specificity is high, a positive test rules in the target disorder
66
New cards
- A highly specific test is rarely positive in the absence of disease (few false positives)
67
New cards
SnNout
- When sensitivity is high, a negative test rules out the target disorder.
68
New cards
- A highly sensitive test is rarely negative in the presence of disease (few false negatives)
69
New cards
Likelihood Ratios
- Thye indicated by how much a given disagnostic test result will increase or decrease the probability of a target condition (quantify shifts in probability for individual patient decisio making)
70
New cards
- Describe likelihood of disorder in someone with as opposed to someone without the disorder
71
New cards
- Minimally affected by prevalence
72
New cards
Likelihood Ratio Scale:
73
New cards
5-10 or .1-.2
Moderate shifts in pretest - posttest probability
74
New cards
Likelihood Ratio Scale:
75
New cards
>10 or
Large and often conclusive changes from pre-test to post-test probability
76
New cards
Likelihood Ratio Scale:
77
New cards
2-5 or .2-.5
Small but sometimes important changes in probability
78
New cards
Likelihood Ratio Scale:
79
New cards
1-2 or .5-1
Small and rarely important changes in probability
80
New cards
Formula for Positive Likelihood ratio
= (Sensitivity)/(1-specificity)
81
New cards
Formula for Negative Likelihood Ratio
= (1-sensitivity)/(Specificity)
82
New cards
Strengths Associated with Likelihood Ratios
- They are not generally prevalence dependent (stable)
83
New cards
- They can be calculated for many levels of the test result
84
New cards
- They can be used to estimate the probability that the target disorder is present in your patient (they quantify shifts in probability for individual patient decision making)
85
New cards
Nomograph
graphic that guides interpretation of likelihood ratios
86
New cards
Nomograph is most meaningful when
pretest probability is higher (ally to individual patient)
87
New cards
Pre-test probability low
regardless of how good the likelihood ratio is, the post-test probability really isn't going to increase that much (and the individual still is unlikely to have the condition)
88
New cards
Pre-test probability too high
the post-test probability doesn't really increase that much; therefore the test isn't really informative because you are already pretty certain that the individual has the condition